Guardant Health
150 hedge funds and large institutions have $4.63B invested in Guardant Health in 2019 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 30 increasing their positions, 37 reducing their positions, and 11 closing their positions.
564% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 11
100% more capital invested
Capital invested by funds: $2.32B → $4.63B (+$2.31B)
70% more funds holding
Funds holding: 88 → 150 (+62)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.73% less ownership
Funds ownership: 71.96% → 70.23% (-1.7%)
19% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 37
46% less call options, than puts
Call options by funds: $19.8M | Put options by funds: $36.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
+$113M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$25.7M |
| 3 |
HCM
Hitchwood Capital Management
New York
|
+$7.21M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.68M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SoftBank Group
Tokyo,
Japan
|
-$76.5M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$19.4M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$12.8M |
| 4 |
Morgan Stanley
New York
|
-$11.3M |
| 5 |
FA
Friess Associates
Greenville,
Delaware
|
-$10.9M |
GH Hedge Fund Activity: Q1 2019 in Review
150 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q1 2019, worth a combined $4.63B — up 100% from $2.32B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new GH positions and 11 closed out — a net gain of 62 holders — while 30 added to existing stakes and 37 trimmed.
The largest buyer was SB Investment Advisers (UK), adding an estimated $113M. The largest seller was SoftBank Group, exiting entirely with an estimated $76.5M sold.
- 150 institutional investors held Guardant Health (GH) as of Q1 2019, up from 88 in Q4 2018.
- Funds reported $4.63B of Guardant Health stock for Q1 2019, up 100% quarter-over-quarter.
- 73 funds opened new Guardant Health positions in Q1 2019 and 11 closed out, a net change of +62 holders.
- The largest Guardant Health buyer in Q1 2019 was SB Investment Advisers (UK), an estimated $113M added.
- The largest Guardant Health seller in Q1 2019 was SoftBank Group, an estimated $76.5M sold.
Based on aggregated 13F filings for Q1 2019.